The Presenilins (PS) gene family is composed of two members: PS1 and PS2. Mutations in PSs are linked to familial Alzheimer's disease (FAD) (1) . PSs are the catalytic subunits of the γ-secretase multimolecular complex, which mediates the intramembranous cleavage of many type I membrane proteins, including amyloid precursor protein (APP) and Notch (2, 3) . Cleavage of substrates produces secreted and intracellular peptides, which in many cases are involved in intracellular signaling pathways. Although the γ-secretase activity of PS is widely characterized, γ-secretase-independent activities have also been described. PS inactivation leads to impaired memory and neurodegeneration (3) (4) (5) , two key features of Alzheimer's disease (AD). Although the importance of PSs in AD is well established, their precise contribution to normal brain function and to FAD pathogenesis are less clear. PSs are expressed in all tissues and cell types. Given the association of PS with FAD, much attention has been paid to the physiological and pathological role of PSs in the brain. (3, 8) . It has been proposed that PSs function as ER Ca 2+ leak channels (9) , as activators of IP 3 R-mediated Ca 2+ release from the ER (10), or activators of SERCA (11) . Despite all these somewhat conflicting data, there is evidence that PSs are important regulators of Ca 2+ homeostasis in neurons and that perturbed Ca 2+ homeostasis could play a key role in the pathogenesis of AD (12) .
By genetically inactivating in mice in either pre-or postsynaptic neurons of the hippocampus, which is a key brain area involved in memory formation, Shen Fig. 1 . Possible γ-secretase-dependent and -independent mechanisms by which PSs regulate RyR levels and synaptic function. PS1 could promote maturation and stability of RyR proteins interacting with RyRs in the ER to facilitate their maturation and targeting to synapses (ER chaperon activity) (1) . Processing by the PS-dependent γ-secretase multimolecular complex-formed by Aph1, Pen2, Nct, and either PS1 or PS2-of an undefined transmembrane protein could release an ER domain (ERD) peptide that assists maturation and/or stabilization of RyR proteins (2) . An intracellular domain (ICD) peptide released by γ-processing of an undefined transmembrane protein could deliver an intracellular signal that promotes RyRs mRNA translation and/or RyRs protein stability (3). PSs could regulate RyRs mRNA translation and/or RyRs protein stability via a still unknown γ-secretase-independent mechanism (4). These functions are impaired by PS deletion, leading to reduced levels and function of RyRs at the presynaptic termini (5).
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and colleagues previously showed that PSs regulate neurotransmitter release (13 RyR-mediated function was also impaired in the PS cDKO neurons, as indicated by reduced RyR agonist-induced Ca 2+ release from the ER using the two different RyR activators caffeine and 4-chloro-m-cresol. In addition, the caffeine-mediated potentiation of excitatory synaptic transmission in the hippocampus was smaller in presynaptic but not postsynaptic PS cDKO mice. Remarkably, the reduced caffeine-induced Ca 2+ response in PS-deficient neurons could be restored by exogenously expressed WT human PS. Although the low levels of RyR could be a compensatory change due to a reduction in SERCA expression or function, no evidence of such reduction was observed. Finally, shRNA knockdown of RyR expression in WT hippocampal cultured neurons to levels comparable to the RyR protein reduction in PS-deficient hippocampal neurons mimicked both the defects exhibited in Ca 2+ homeostasis (e.g., caffeine-induced Ca 2+ release) and presynaptic function (e.g., synaptic facilitation by repetitive activity). Together, these findings strongly suggest that PS regulates presynaptic Ca 2+ and neurotransmitter release mainly by controlling RyR protein expression.
Although an in-depth analysis of RyR levels in synapses is still needed, the data presented here suggest that the synaptic deficits observed in PS cDKO mice depend on reduced levels and function of RyRs at the presynaptic termini. A big question raised by the study of Wu et al. is how exactly PS deletion causes a reduction in RyR proteins. Although changes at transcriptional level were excluded (5), PSs could promote translation of RyRs mRNAs and/or maturation/stability of RyRs proteins. Potential mechanisms are summarized in Fig. 1 . Cleavage by γ-secretase of a substrate, whose identity will have to be determined, may generate an ER domain (ERD) peptide that regulates maturation/stability of RyR proteins and/or an intracellular domain (ICD) peptide that promotes RyRs mRNA translation and/or RyRs protein stability. Alternatively, PSs could physiologically regulate RyRs via a γ-secretase-independent manner. For example, A big question raised by the study of Wu et al. is how exactly PS deletion causes a reduction in RyR proteins.
acting as an ER chaperone, PS1 could regulate RyR maturation and stability, as recently proposed for PS1 in the maturation and lysosomal targeting of v-ATPase V0a1 (14) . Finally, PS may regulate RyRs levels via a yet-to-be determined γ-secretaseindependent mechanism. Regardless of the exact mechanism, loss of PS function as in PS cDKO mice would result in reduced levels and function of RyRs at the presynaptic termini.
It will be important to determine whether PSs regulate RyR levels by a γ-secretasedependent or -independent mechanism. Interfering with other essential components of the γ-secretase multimolecular complex, such as Nct, Pen2, or Aph1, could be useful to address this issue. If PSs regulate RyR protein expression via their role as γ-secretase subunits, Nct, Aph1, and/or Pen2 cKO mice should show reduced levels of RyR proteins and reduced function of RyRs at the presynaptic termini. Finding normal RyR levels and synaptic function in animals in which γ-secretase activity has been removed by deletion of any one of the other essential γ-secretase components would indicate that PSs regulate RyRs levels/function through a γ-secretaseindependent mechanism.
Given that the vast majority of FAD cases are linked to mutations in PSs, it is logical to ask whether the function described by Wu et al. (5) is altered by FAD-linked mutations. It is assumed that PS-linked FAD mutations cause abnormal APP processing, which results in a relative increase of amyloidogenic Ab42 peptide levels, thereby promoting amyloidosis and neurodegeneration (15) . Interestingly, however, a large number of pathogenic PS mutations result in partial loss of γ-secretase function (16, 17) . Thus, FAD-linked PS mutations may lead to reduced RyRs levels and activity, which may contribute to neuronal degeneration and dementia. Animal models carrying pathogenic PS mutations knocked-in the endogenous mouse PS allele can help address this question (17) (18) (19) . These models would likely mimic with close quantitative and spatiotemporal accuracy the alteration in γ-secretase function caused by FAD-linked mutations in humans. PS knock-in mice showing a reduction in RyR protein levels and the associated synaptic deficits would support the hypothesis that reduced RyRs levels and activity is relevant to AD pathogenesis. If this is the case, boosting RyR activity could represent a novel strategy for disease-modifying therapeutic interventions in AD.
